Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria
Open Access
- 19 February 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (3) , ofae092
Abstract
We determined pretreatment and acquired human immunodeficiency virus (HIV) drug resistance among children with HIV type 1 (HIV-1) in Jos, Nigeria. The majority (71%) of those who failed first-line antiretroviral therapy were on a nevirapine-containing regimen. The prevalence of pretreatment (48%) and acquired (76%) HIV drug resistance mutations was high in our study. Wider access to HIV drug resistance testing after treatment failure is necessary to optimize second-line treatment options among children with HIV in Nigeria.Keywords
Funding Information
- STAMINA
- Fogarty International Center
- Office of the Director
- National Institute of Neurological Disorders and Stroke
- National Institute of Nursing Research
- National Institutes of Health (D43 TW010130)
- US Department of Health and Human Services
- Health Resources and Services Administration (U51HA02522- 01-01)
- Centers for Disease Control and Prevention (PS 001058)
This publication has 15 references indexed in Scilit:
- Antiviral Resistance and Correlates of Virologic Failure in the first Cohort of HIV-Infected Children Gaining Access to Structured Antiretroviral Therapy in Lima, Peru: A Cross-Sectional AnalysisBMC Infectious Diseases, 2013
- Antiretroviral resistance in HIV-infected Saudi children failing first-line highly active antiretroviral therapyAnnals of Saudi Medicine, 2012
- Transmitted HIV Resistance to First-Line Antiretroviral Therapy in Lima, PeruAIDS Research and Human Retroviruses, 2012
- HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapineAIDS, 2011
- Impact of HIV Type 1 Subtype on Drug Resistance Mutations in Nigerian Patients Failing First-Line TherapyAIDS Research and Human Retroviruses, 2011
- Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in MaliJournal of Antimicrobial Chemotherapy, 2009
- Early Archiving and Predominance of Nonnucleoside Reverse Transcriptase Inhibitor–Resistant HIV‐1 among Recently Infected Infants Born in the United StatesThe Journal of Infectious Diseases, 2007
- Nevirapine Resistance Viral Mutations After Repeat Use of Nevirapine for Prevention of Perinatal HIV TransmissionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Broad Nucleoside Reverse‐Transcriptase Inhibitor Cross‐Resistance in Human Immunodeficiency Virus Type 1 Clinical IsolatesThe Journal of Infectious Diseases, 2003
- Resistance profile and cross‐resistance of HIV‐1 among patients failing a non‐nucleoside reverse transcriptase inhibitor‐containing regimen*Journal of Medical Virology, 2001